Open the newsletter to watch the White House for free
Your guide to what the second period of Trump means to Washington, business and the world
The shares of cannabis companies jumped on Monday after Donald Trump drew attention to the potential benefits that hemp used from cannabis to higher health care.
The US President used his social account in fact on Sunday to share a video from the Commonwealth project, a group of advocacy to integrate medical cannabis in the prevailing health care of more than 65 years, after several weeks of saying that his administration was declining the possibility of reclassifying marijuana as a less dangerous drug.
The stocks in Tilray Brands, a hemp, increased by 36 percent after a short period of Wall Street bell on Monday. The growth of the umbrella, which focuses on hemp, jumped by 13 percent, and the Kronos Group has acquired 14 percent.
Trump The video, which made the potential benefits of the use of the CBD (CBD) that could have the elderly, including low pain and stress, improving sleep and slowing the development of the disease.
The video said that it is time to educate doctors on the Endocannabinoid system in the body, which organizes things like mood and sleep, and “providing medical care coverage of the Convention on Biological Diversity”.
The video invitation to cover comes under Medicare, a federal health insurance program for people in the United States between the ages of 65 years or older, while some senior legislators are considering the policy changes that can be shaken by CBD Market.
In August, Trump said that his administration was declining the possibility of re -classification of marijuana at the federal level, a move that will follow him from President Joe Biden’s efforts to convert cannabis from the so -called drugs in Table 1 to the third table. About 40 countries allow medical marijuana.
The reclassification of drugs would allow cannabis companies to take advantage of the standard business tax discounts from which they are banned at the present time.
Trump’s comments – and the re -published CTP video – gave some hope after uncertainty about the organizational environment that knocked on stock prices during the past year.
Mitch McConnell, Republican Senator from Kentucky, who defended the legal hemp seizure through the Farm Bill 2018 during the Trump administration, sought to decline this legislation by preventing hemp derivatives with a quantitative amount of quadruple of the quadruple of virusanabinol (THC).
A bill in California prohibits the sale of mascaranthini products outside the approved dispensaries awaiting the signing of the Democratic Governor Gavin News.
The difficulty of producing CBD products below at least a level of THC means a ban on hemp with any small amount of the compound that can have negative repercussions for us hemp farmers.
https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fimages.ft.com%2Fv3%2Fimage%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252F358fb493-57c7-4133-9e6f-539afd96c228.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900
Source link